Clinical Trials Browser

Expanded_access × 30 days × Clear all

NCT07535359 2026-04-21

Medical Access Program for Ifinatamab Deruxtecan in 3L+ Pretreated Extensive-stage Small Cell Lung Cancer

Small Cell Lung Carcinoma

NCT05398640 2026-04-20

Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release

Melanoma

NCT07536815 2026-04-17

An Open-Label, Multicenter, Non-Randomized Expanded Access Protocol (EAP) Designed to Provide Leronlimab to Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer (mTNBC)

Triple Negative Breast Neoplasms

NCT04085653 2026-04-14

Managed Access Programs for BYL719, Alpelisib

Breast Neoplasms

NCT06443944 2026-04-14

An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Urologic Neoplasms

NCT01163383 2026-04-13

131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol

Neuroblastoma

NCT05038631 2026-04-13

Managed Access Programs for LEE011, Ribociclib

Breast Neoplasms

NCT06877676 2026-04-13

Pre-Approval Expanded Access Study for TAR-200 Treating Physician Use

Approved for marketing

Non-Muscle Invasive Bladder Neoplasms

NCT05776134 2026-04-08

Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel

LymphoidOther hematologic neoplasm

Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06834074 2026-04-07

NVL-655-EAP

Carcinoma, Non-Small-Cell Lung

NCT06948955 2026-04-02

Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors

GastrointestinalSarcoma

Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors

NCT05041036 2026-04-01

Individual Patient Compassionate Use of Nirogacestat

Desmoid Tumors

NCT05100134 2026-04-01

Managed Access Programs for LDK378, Ceritinib

No longer available

LymphoidPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic

NCT07502716 2026-03-31

Compassionate Use of Ubamatamab

Sarcoma

NCT06761976 2026-03-30

Expanded Access to Provide Sevabertinib (BAY 2927088) for the Treatment of Locally Advanced or Metastatic NSCLC With HER2 Mutation

Neoplasms

NCT05028166 2026-03-27

Individual Patient Compassionate Use of Mirdametinib

Neurofibromatoses, Neurofibroma, Plexiform

NCT06810141 2026-03-27

ResQ132EX-NMIBC: Expanded Access Use of Recombinant Bacillus Calmette-Guérin in Nonmuscle Invasive Bladder Cancer

Non-Muscle Invasive Bladder Neoplasms

NCT07497984 2026-03-27

ITM11 Expanded Access Program

Meningioma